CJH fundamentals
An in-depth look to CanSino Biologics Inc. operating, investing, and financing activities
CJH free cash flow for Q1 24 is -25.77 M EUR. For 2023, CJH free cash flow was -200.05 M EUR and operating cash flow was -124.99 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM